Abstract
We are trying to illustrate operative, short-term, and pathological outcomes of transanal total mesorectal excision (TaTME) as a surgical procedure for patients who are suffering cancer in the lower or middle rectum. This study included 25 consecutive patients who underwent TaTME for the mid and low cancer rectum. The primary outcome measures included frequency of postoperative (PO) bleeding, leakage, ileus, days to regain bowel function, days for Foley’s removal, and erectile function. The secondary outcome measures included operation time, status of resection margins, number, the quality of TME, and duration PO hospital stay. No recorded intraoperative complications. The mean hospital stay was 6.9 ± 2.6 days. The mean duration need for urinary catheter removal and flatus passage were 2.4 ± 2.1 and 1.5 + 0.9 days, respectively. The mean IPSS was returned to normal 12 months after surgery. The mean distal margin distance was 1.9 ± 1.1. Circumferential margin distance was > 1 mm in 23 (92%) patients. The mesorectum was complete in 22 (88%) patients. The survival rate was 88% over 3 years. TaTME could be considered as a safe, feasible, and effective surgical modality for patients who had mid and lower rectal tumors with an excellent pathological outcome.
Similar content being viewed by others
References
Shanna A, Harvey J, Charles S, Leona A, Sree H, Nikhil H, Michael H (2015) Anorectal cancer: critical anatomic and staging distinctions that affect use of radiation. Ther Radio 35(7):2090–2107
Siegel R, Miller K, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7–30
Heald R, Husband E, Ryall R (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69(10):613–616
Heald RJ (1988) The “holy plane” of rectal surgery. J R Soc Med 81:503–508
Joseph M, Pierre A, Matthew R (2017) Recent advances in the management of rectal cancer: no surgery, minimal surgery or minimally invasive surgery. World J Gastrointest Surg 9(6):139–148
Jayne D, Thorpe H, Copeland J, Quirke P, Brown J, Guillou P (2010) Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 97:1638–1645
Jayne D, Brown J, Walker J, Quirke P, Guillou P (2005) Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 92:1124–1132
Lanfranco A, Castellanos A, Desai J, Meyers W (2004) Robotic surgery: a current perspective. Ann Surg 239:14–21
Daniel L, Freddy P, Steffen F, Anne J, Christine S, Constant J, Elizabeth V (2010) Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg 252(6)
Bjorn M, Perdawood S (2015) Transanal total mesorectal excision: a systematic review. Dan Med J 62:A5105
Autschbach F (2005) The pathological assessment of total mesorectal excision: what are the relevant resection margins? Inst Path Heid Univ Im Neu Feld 220/221:69120
Harmeet K, Haesun C, Nancy Y, Gaiane M, Corey T, Ping H et al (2012) MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. RadiogGraph 32(2)
Hacking C, Yang N (2018) Rectal cancer (staging). Radiopaedia
Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50(1):103–112
Stevenson A, Solomon M, Lumley J, Hewett P, Clouston A, Gebski V, Davies L, Wilson K, Hague W, Simes J, ALaCaRT Investigators (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363
Fleshman J, Branda M, Sargent D, Boller A, George V, Abbas M et al (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355
Serra A, Mora L, Alcantara M, Caro T, Gomez D, Navarro S (2014) Transanal endoscopic surgery in rectal cancer. World J Gastroenterol 20(33):11538–11545
Keller D, Haas E (2016) Transanal minimally invasive surgery: state of the art. J Gastrointest Surg 20(2):463–469
Wolthuis A, de Buck van A, D’Hoore A (2014) Laparoscopic natural orifice specimen extraction-colectomy: a systematic review. World J Gastroenterol 20(36):12981–12992
Motson R, Lacy A (2015) The rationale for transanal total mesorectal excision. Dis Colon Rectum 58(9):911–913
Denost Q, Adam J, Pontallier A, Celerier B, Laurent C, Rullier E (2015) Laparoscopic total mesorectal excision with coloanal anastomosis for rectal cancer. Ann Surg 261(1):138–143
Bin M, Peng G, Yongxi S, Cong Z, Changwang Z, Longyi W, Hongpeng L, Zhenning W (2016) Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer J 7. https://doi.org/10.1186/s12885-016-2428-5
Chen C, Lai Y, Jiang J, Chu C, Huang I, Chen W et al (2015) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol
Fernandez H, Delgado S, Castells A, Tasende M, Momblan D, Díaz del Gobbo G et al (2015) Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Sur 261(2):221–227
Annibale D, Graziano P, Igor M, Vito P, Giorgio L, Paolo M, Giovanni A (2013) Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc 27:1887–1895
Simillis C, Hompes R, Penna M, Rasheed S, Tekkis P (2016) A systematic review of transanal total mesorectal excision. Is this the future of rectal cancer surgery? Color Dis 18(1):19–36
Nagtegaal I, van de Velde C, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734
Wasserberg N, Gutman H (2008) Resection margins in modern rectal cancer surgery. J Surg Oncol 98:611–615
Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303–312
Author information
Authors and Affiliations
Contributions
Concept and design: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Manuscript preparation: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Data and statistical analysis: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Manuscript editing: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Literature search: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Manuscript review: Ashraf MA, Ahmed MZ, Mohamed T, Shaimaa KD
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Patient Consent
Patient informed consents were obtained before the operation, as with all procedures.
Ethics Approval
This data collection was approved by the Ethical Committee of our hospital.
Additional information
Synopsis
In this study, we are trying to illustrate the operative, clinical, and pathological outcomes of TaTME as a surgical procedure for patients who are suffering cancer in the lower or middle rectum. We included 25 patients in our study over 3 years. Operations done laparoscopically, specimens examined histologically then patient followed postoperatively.
Rights and permissions
About this article
Cite this article
Abdelkader, A.M., Zidan, A.M., Younis, M.T. et al. Transanal Total Mesorectal Excision for Treatment of Carcinoma in the Middle or Lower Third Rectum: the Technical Feasibility of the Procedure, Pathological Results, and Clinical Outcome. Indian J Surg Oncol 9, 442–451 (2018). https://doi.org/10.1007/s13193-018-0808-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-018-0808-9